Quantum Biopharma Class B Subordinate Voting Shares
QNTM
14 hedge funds and large institutions have $553K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
116% more capital invested
Capital invested by funds: $256K → $553K (+$296K)
56% more funds holding
Funds holding: 9 → 14 (+5)
0.01% more ownership
Funds ownership: 3.63% → 3.64% (+0.01%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JWCA
J.W. Cole Advisors
Tampa,
Florida
|
+$72.4K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$18.4K |
| 3 |
Morgan Stanley
New York
|
+$14.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$9.28K |
| 5 |
TIM
Thompson Investment Management
Madison,
Wisconsin
|
+$1.87K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$115K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.07K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$103 |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$55 |
| 5 |
AWM
Avior Wealth Management
Omaha,
Nebraska
|
-$11 |
QNTM Hedge Fund Activity: Q1 2025 in Review
14 of the 7,462 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q1 2025, worth a combined $553K — up 116% from $256K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new QNTM positions and 2 closed out — a net gain of 5 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was J.W. Cole Advisors, opening a new position worth an estimated $72.4K. The largest seller was AdvisorShares Investments, cutting an estimated $115K.
- 14 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q1 2025, up from 9 in Q4 2024.
- Funds reported $553K of Quantum Biopharma Class B Subordinate Voting Shares stock for Q1 2025, up 116% quarter-over-quarter.
- 7 funds opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q1 2025 and 2 closed out, a net change of +5 holders.
- The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q1 2025 was J.W. Cole Advisors, an estimated $72.4K added.
- The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q1 2025 was AdvisorShares Investments, an estimated $115K sold.
Based on aggregated 13F filings for Q1 2025.